Nexgen Biolabs Affiliate Program Joins MoreNiche
(PRWEB) July 16, 2013 -- The Nexgen Biolabs merchant has two products for affiliates to promote; both products are designed to combat anxiety and ADHD and the ingredients in these two products have been extensively researched and clinically proven to provide excellent results with minimal side-effects.
AdderRx is the first of two products and helps mental focus and endurance to improve alertness and give the user the ability to perform at their very best.
XanRx is an anti-anxiety supplement and works by improving relaxation, reducing feelings of stress and promoting well-being to help the user overcome their panic attacks and anxiety.
This new affiliate program is available via the MoreNiche affiliate network and with over 1,222,000 monthly exact match searches for the search term ‘adderall’ and 74,000 for the search term ‘anti-anxiety’ there is fantastic scope for affiliates to do very well from promoting this product.
The MoreNiche network also provides a number of great benefits for affiliates and is one the most transparent and trustworthy networks out there. Some of the great benefits include product specific affiliate managers who provide excellent guidance and support, as well as lifetime cookies, so that affiliates profit from repeat sales!
The earning potential for this program is extremely high, more and more people are searching for a non-prescription alternative to anti-anxiety medication and with a high 25% commission on a $59.99 priced bottle of either AdderRX or XanRx, affiliates could see a high income.
The Nexgen Biolabs products really define the term ‘cutting edge’ and the company behind the products are already global leaders in developing supplements that strive to meet unmet health and medical needs such as anxiety.
More information about the affiliate program and the Nexgen Biolabs products can be found on the MoreNiche affiliate network.
Will Haswell, MoreNiche Affiliate Network, http://www.moreniche.com, +44 (0)1159 690906, [email protected]
Share this article